If Bupropion is any indication, this is going to be an extremely short-lived NDRI that gets converted into its non-dopaminergic metabolite so rapidly as to be orally inactive.
Oh, and expect a significant chance of seizures at anything approaching a recreational dose.
I really hope they didn't cut down any poor Sassafras trees for that Methylenedioxy group.